Adagio Medical Holdings, Inc. (ADGM) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-03-09

Key Insights

The CEO, Todd Usen, has been granted 800,000 stock options as part of the company's 2024 Equity Incentive Plan. This suggests the company is incentivizing its leadership to drive long-term growth and value creation.
The options will vest over a four-year period, aligning the CEO's interests with those of shareholders. This type of compensation structure is common for public company executives.
The exercise price of the options is $0.977, which appears to be at or near the current market price, indicating the company is not issuing discounted options to insiders.

Want the newest filings?

This analysis covers the filing from 2026-03-09. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-03-09

Deborah Kaster, the Chief Financial Officer of Adagio Medical Holdings, Inc., has acquired 490,500 employee stock options with an exercise price of $0.977 per share.
The options will vest over a four-year period, with 25% vesting on October 20, 2026 and the remaining shares vesting in equal monthly installments over the next 36 months.
This equity grant suggests that Kaster is being incentivized to continue in her role and drive the company's long-term success.

Other reports for Adagio Medical Holdings, Inc.

Current Report Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.